On April 12, 2023, the 2023 Shenzhen Quality City Promotion Conference and the 10th Anniversary Celebration of the Shenzhen Quality City Promotion Association were held at the Shenzhen Silver Lake International Conference Center. The conference solemnly commended outstanding entrepreneurs who won the 9th “Shenzhen Quality City Gold Medal” and nomination awards. Dr. Hu Junyuan, chairman of Shenzhen Beike Biotechnology Co., Ltd., won the 9th “Shenzhen Quality City Gold Medal”. At the same time, after deliberation at the meeting, Dr. Hu Junyuan was added as the vice president of the third council of Shenzhen Quality City Promotion Association, and Beike Biotechnology became the vice president unit of Shenzhen Quality City Promotion Association.
As the “highlight” of the annual Quality City Promotion Conference, the Shenzhen Quality City Gold Medal Award Ceremony has attracted much attention. This award was established in 2013 and is positioned as the highest personal honor in the field of quality in Shenzhen. It is awarded to the main persons in charge of Shenzhen enterprises/organizations who have firmly established quality first awareness, always adhere to the drive for innovation, actively fulfill social responsibilities, and have made outstanding contributions in the process of building “Shenzhen Quality” and promoting “Quality Strong City”. It is intended to set a benchmark for building a “quality-strong city”, encourage enterprises and entrepreneurs in the city to practice high-quality development concepts, benchmark first-class operations and management, and create modern enterprises with core market competitiveness. The “Shenzhen Quality City Gold Medal” is awarded once a year, with no more than 10 people in each session. It has been successfully held for eight times before. 66 entrepreneurs including BYD Chairman and President Wang Chuanfu and ZTE Chairman Li Zixue have won this honor.
In the development process of Beike Biotechnology, it has always adhered to the core concept of “quality is the lifeline of an enterprise”, persisted in R&D technological innovation, strictly controlled product quality, gained popularity and reputation with a rigorous and serious style, and achieved rapid development of the enterprise. The cell industry is related to life and health, and quality management is particularly important. As a leader in the field of cells, Beike Biotechnology has started the road to building a corporate quality management system early.With “customer focus” as the first driving force for quality construction, a complete internal high-quality management standard has been formed. Through 910+ quality control nodes, 870+ quality records, and 680+ quality standard documents, we coordinate operations to improve the closed loop of cell quality from donor to preparation to testing, ensuring cell quality safety and providing customers with the strongest technical support.
At the same time, Beike Biotechnology also actively participates in the formulation of industry standards and focuses on the cultivation of industry talents. It was drafted by the Shenzhen Municipal Market Supervision and Administration Bureau in conjunction with the Shenzhen Municipal Development and Reform Commission, the Shenzhen Institute of Standards and Technology and Beike Biotechnology. inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline;”>”Cell Preparation Center Construction and Management Specifications” was officially released in June 2016; “Comprehensive Cell Bank Construction and Management Specifications” was officially released in September 2017; providing useful reference for the formulation of industry standards for cell therapy technology in my country. At the end of 2018, Beike Biotechnology obtained the Shenzhen City’s font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline;”>”Synchronous Standardization and Innovation Demonstration Enterprise” honor, at the end of 2019, Beike Biotech was approved to become “Shenzhen Standardization Innovation Demonstration Base”. At the end of 2020, Beike Biotech took the lead in formulating Shenzhen’s font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline;”>”Transportation Technology and Management Specifications for Human Living Samples”, “Technology and Management Specifications for Transportation of Human Cell Products”, on March 17, 2023, “Cell Culture Clean Room Design Technical Specifications”National standard was officially released. The implementation of a series of regulations will surely lead and accelerate the process of legalization, standardization and professionalization of the cell therapy industry. Beike Biotechnology also actively promotes the cultivation of industry talents. Under the guidance of the Shenzhen Municipal Human Resources and Social Security Bureau, it has established a professional and technical qualification assessment system for cell preparation engineers and cell quality management engineers. It has provided a large number of talents for industry training, set a good industry model for the domestic stem cell industry, and has become a leading cutting-edge technology brand in the cell field.
Building a quality power is an important measure to promote high-quality development and promote the transformation of our country’s economy from large to strong. Currently, a new round of scientific and technological revolution and industrial transformation are developing in depth, triggering profound changes in quality concepts, mechanisms, and practices. As a key factor in prospering international trade, promoting industrial development, and improving people’s livelihood and well-being, quality has increasingly become the focus of economic, trade, science and technology, culture and other fields. To this end, the Central Committee of the Communist Party of China and the State Council issued the “Outline for Building a Quality Power”, which states that the focus of promoting development must be shifted to improving quality and efficiency, cultivating new advantages in economic development with technology, standards, brands, quality, services, etc. as the core, promoting the transformation of Made in China to Creation in China, China Speed to China Quality, and Chinese Products to Chinese Brands, and unswervingly promote the construction of a Quality Power. Following the country’s high-quality development footsteps,Beike Biotech will also adhere to its original aspirations, continue to promote the company’s higher-quality sustainable development, focus on improving product and service quality, promote brand building, enhance industrial quality competitiveness, actively connect with international advanced technologies, rules, and standards, and contribute to the all-round construction of a quality power.